AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Clinical trials for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE explained in plain language.
Never miss a new study
Get alerted when new AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE trials appear
Sign up with your email to follow new studies for AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Alzheimer's agitation drug safety trial halted early
Disease control TerminatedThis study tested the long-term safety of AXS-05, an experimental drug for agitation in people with Alzheimer's disease. It included 139 adults who had already completed earlier studies. The trial was terminated early, and its main goal was to track side effects, not to cure Alzh…
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Alzheimer's agitation drug study halted early
Symptom relief TerminatedThis study looked at the long-term safety of an experimental drug, AVP-786, for treating agitation in people with Alzheimer's disease. It was an extension of earlier phase 3 studies and involved about 1,200 participants. The study was terminated, meaning it stopped early, and the…
Matched conditions: AGITATION IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER'S TYPE
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated May 26, 2026 09:52 UTC